SS18 and synovial sarcoma: Strikingly, the up- and down-regulated pathways, based on the expression changes of the related genes, verified our hypothesis as several of the most enhanced or suppressed biological processes are common to both TAK-981-treated SS cells and SS18::SSX-genetically inhibited SS cells (Fig. 4A).